D. van de Beek

New England Journal of Medicine · 2002–2021

A researcher in the Science corpus: 9 papers; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Who trusts D. van de Beek overall

  1. Nicholas J. Horton
  2. Emmanuel Carrera
  3. K. Kleinman

Papers from D. van de Beek's perspective

Ordered by how strongly the researchers D. van de Beek trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. (Jornal de Pediatria)
  2. Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. (Journal of Infectious Diseases)
  3. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children (The Pediatric Infectious Disease Journal)
  4. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. (New England Journal of Medicine)
  5. Efficacy and safety of recombinant human activated protein C for severe sepsis. (New England Journal of Medicine)
  6. Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death. (New England Journal of Medicine)
  7. Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus. (Clinical Infectious Diseases)
  8. Community-acquired bacterial meningitis in adults. (New England Journal of Medicine)
  9. Mendelian Randomization Analysis With Multiple Genetic Variants Using Summarized Data (Genetic Epidemiology)
  10. Partitioning heritability by functional annotation using genome-wide association summary statistics (Nature Genetics)

Their papers